Annual Current Ratio
0.84
-3.44-80.37%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual current ratio is 0.84, with the most recent change of -3.44 (-80.37%) on December 1, 2023.
- During the last 3 years, NRSN annual current ratio has fallen by -5.54 (-86.83%).
- NRSN annual current ratio is now -96.60% below its all-time high of 24.68, reached on December 31, 2019.
Performance
NRSN Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
0.21
-0.25-54.35%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly current ratio is 0.21, with the most recent change of -0.25 (-54.35%) on September 1, 2024.
- Over the past year, NRSN quarterly current ratio has dropped by -0.05 (-19.23%).
- NRSN quarterly current ratio is now -98.90% below its all-time high of 19.12, reached on December 1, 2021.
Performance
NRSN Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
NRSN Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.4% | -19.2% |
| 3 y3 years | -86.8% | -98.6% |
| 5 y5 years | -96.6% | - |
NRSN Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.6% | at low | -98.9% | at low |
| 5 y | 5-year | -96.6% | at low | -98.9% | at low |
| alltime | all time | -96.6% | at low | -98.9% | at low |
NeuroSense Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 0.21(-54.3%) |
| Jun 2024 | - | 0.46(+76.9%) |
| Mar 2024 | - | 0.26(-69.0%) |
| Dec 2023 | 0.84(-80.4%) | 0.84(-53.8%) |
| Sep 2023 | - | 1.82(-27.8%) |
| Jun 2023 | - | 2.52(-10.0%) |
| Mar 2023 | - | 2.80(-34.6%) |
| Dec 2022 | 4.28 | 4.28(-60.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 10.96(-27.4%) |
| Jun 2022 | - | 15.09(+32.1%) |
| Mar 2022 | - | 11.42(-40.3%) |
| Dec 2021 | 19.12(+199.7%) | - |
| Dec 2021 | - | 19.12(+136.6%) |
| Jun 2021 | - | 8.08(+26.6%) |
| Dec 2020 | 6.38(-74.1%) | 6.38 |
| Dec 2019 | 24.68 | - |
FAQ
- What is NeuroSense Therapeutics annual current ratio?
- What is the all time high annual current ratio for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual current ratio year-on-year change?
- What is NeuroSense Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly current ratio year-on-year change?
What is NeuroSense Therapeutics annual current ratio?
The current annual current ratio of NRSN is 0.84
What is the all time high annual current ratio for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual current ratio is 24.68
What is NeuroSense Therapeutics annual current ratio year-on-year change?
Over the past year, NRSN annual current ratio has changed by -3.44 (-80.37%)
What is NeuroSense Therapeutics quarterly current ratio?
The current quarterly current ratio of NRSN is 0.21
What is the all time high quarterly current ratio for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly current ratio is 19.12
What is NeuroSense Therapeutics quarterly current ratio year-on-year change?
Over the past year, NRSN quarterly current ratio has changed by -0.05 (-19.23%)